FTSE opens higher, led by AstraZeneca ahead of vaccine approval

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

UK stocks opened higher on Tuesday, led by AstraZeneca on expectations that its coronavirus vaccine could be approved for use as soon as Tuesday.

At 08:30, the benchmark FTSE 100 index was up 109 points, or 1.68%, at 6,611.64.

Drugmaker AstraZeneca was among the biggest gainers, up 4% to £75.52, on reports that health regulators in the UK could announce their decision to approve the vaccine for use on Tuesday.

AstraZeneca also reported that it had won approval in Japan for a drug to treat three cancers.

Insurance company Admiral climbed 3% to £30.11 after reaching an agreement to sell Penguin Portals and Preminen comparison businesses to RVU, the comparison division of ZPG, for £508 million.

Betting company William Hill was up 0.2% to 270.5p after announcing that its £2.9 billion sale to Caesars was expected to be completed in the second quarter of 2021.

Shearwater jumped 10% to 154.5p after the cybersecurity and risk management company said revenue growth seen in October and November had continued into December, and also announced new business wins.